Get the Stockscreener App
18.97
4.86%
0.88
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $18.97, with a volume of 486.13K.
It is up +4.86% in the last 24 hours and up +21.29% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
See More
Previous Close:
$18.09
Open:
$18.2
24h Volume:
486.13K
Relative Volume:
1.19
Market Cap:
$834.84M
Revenue:
$159.01M
Net Income/Loss:
$-21.72M
P/E Ratio:
-36.48
EPS:
-0.52
Net Cash Flow:
$-20.63M
1W Performance:
+4.00%
1M Performance:
+21.29%
6M Performance:
+108.00%
1Y Performance:
+116.06%
1-Day Range:
$18.20
$19.00
1-Week Range:
$17.63
$19.00
52-Week Range:
$5.55
$19.00
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
18.97 | 834.84M | 159.01M | -21.72M | -20.63M | -0.52 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
Axogen stock soars to 52-week high, touches $18.99 - Investing.com
AxoGen (NASDAQ:AXGN) Reaches New 1-Year High – Time to Buy? - Defense World
Axogen (FRA:LT3) Earnings Yield % : N/A% (As of Jan. 19, 2025) - GuruFocus.com
Axogen (FRA:LT3) 5-Year Yield-on-Cost % : 0.00 (As of Jan. 18, 2025) - GuruFocus.com
Assenagon Asset Management S.A. Sells 484,570 Shares of AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
AxoGen (NASDAQ:AXGN) Sets New 52-Week HighStill a Buy? - MarketBeat
AxoGen (AXGN) Moves 18.2% Higher: Will This Strength Last? - MSN
AxoGen, Inc. (NASDAQ:AXGN) Shares Bought by JPMorgan Chase & Co. - Defense World
Barclays PLC Raises Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Is Axogen (NASDAQ:AXGN) Using Too Much Debt? - Simply Wall St
Learn to Evaluate (AXGN) using the Charts - Stock Traders Daily
AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
AxoGen (NASDAQ:AXGN) Hits New 12-Month High – Time to Buy? - Defense World
AxoGen (NASDAQ:AXGN) Reaches New 12-Month HighHere's What Happened - MarketBeat
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Axogen (STU:LT3) Enterprise Value : €694.5 Mil (As of Jan. 10, 2025) - GuruFocus.com
AxoGen (NASDAQ:AXGN) Trading Up 6.7%Here's What Happened - MarketBeat
Axogen stock soars to 52-week high, hits $17.24 - Investing.com India
Axogen sees Q4 revenue to be $49.4M - MSN
Axogen Reports Strong Revenue Growth and Market Expansion - TipRanks
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024 - The Manila Times
Axogen Reports Strong Q4: Revenue Surges 15% to $49.4M as Surgical Solutions Gain Traction - StockTitan
Axogen (STU:LT3) Cash Flow for Lease Financing : €0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Axogen (STU:LT3) GF Value Rank : 3 (As of Jan. 09, 2025) - GuruFocus.com
Axogen (STU:LT3) Revenue per Share : €3.81 (TTM As of Sep. 2024) - GuruFocus.com
First Light Asset Management, LLC Increases Stake in Axogen Inc - GuruFocus.com
Principal Financial Group Inc. Makes New Investment in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen: Well Placed To Capitalize Growth At Higher Multiples (NASDAQ:AXGN) - Seeking Alpha
Axogen (FRA:LT3) Total Assets : €173.0 Mil (As of Sep. 2024) - GuruFocus.com
Axogen (FRA:LT3) Short-Term Capital Lease Obligation : €1.7 Mil (As of Sep. 2024) - GuruFocus.com
Axogen (FRA:LT3) PS Ratio : 4.17 (As of Jan. 05, 2025) - GuruFocus.com
AxoGen (NASDAQ:AXGN) Trading Down 4.8%What's Next? - MarketBeat
Jane Street Group LLC Cuts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Short Interest Down 7.3% in December - MarketBeat
Geode Capital Management LLC Buys 31,612 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Barclays PLC Purchases 39,182 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Barclays PLC Increases Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Shares Acquired by Geode Capital Management LLC - MarketBeat
Axogen Inc (AXGN) Shares Down 3.3% on Dec 30 - GuruFocus.com
Franklin Resources Inc. Has $1.08 Million Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen Inc (AXGN) Shares Down 4.15% on Dec 27 - GuruFocus.com
State Street Corp Purchases 95,051 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
State Street Corp Acquires 95,051 Shares of AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run? - MSN
AxoGen (NASDAQ:AXGN) Shares Down 4.8%Here's What Happened - MarketBeat
Axogen, Inc. (NASDAQ:AXGN) Looks Just Right With A 29% Price Jump - Simply Wall St
AxoGen (NASDAQ:AXGN) Hits New 52-Week HighStill a Buy? - MarketBeat
(AXGN) Trading Advice - Stock Traders Daily
Axogen stock soars to 52-week high, reaches $15.95 - Investing.com
With 78% ownership in Axogen, Inc. (NASDAQ:AXGN), institutional investors have a lot riding on the business - Simply Wall St
Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year? - MSN
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):